Despite hundreds of potential therapies for COVID-19 seeking to make their case, very few have crossed the finish line. One graduate candidate, Regeneron’s two-antibody cocktail, has earned early plaudits – and now a pharmaceutical giant is jumping on board to boost production in a big way. Regeneron will partner with …
Read More »
In the early days of the COVID-19 pandemic, Sanofi and Regeneron launched an ambitious plan to test rheumatoid arthritis with Kevzara in desperately ill patients. But after the first warning signs, a phase 3 failure has forced drug makers to make their judgment in the United States. Sanofi and Regeneron …
Read More »
In the month ending April 7, 423 cancer patients at Memorial Sloan Kettering Cancer Center were diagnosed with COVID-19, 20% of whom developed severe respiratory symptoms. That in itself was not surprising, given that cancer patients are immunocompromised and therefore face an increased risk of fighting the virus. But a …
Read More »